INBX
Price
$82.05
Change
-$2.68 (-3.16%)
Updated
Jul 31 closing price
Capitalization
1.2B
16 days until earnings call
Intraday BUY SELL Signals
SGMT
Price
$7.11
Change
-$0.20 (-2.74%)
Updated
Jul 31 closing price
Capitalization
439.06M
16 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

INBX vs SGMT

INBX vs SGMT Comparison Chart in %
View a ticker or compare two or three
VS
INBX vs. SGMT commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INBX is a Hold and SGMT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2026
Stock price -- (INBX: $82.05 vs. SGMT: $7.11)
Brand notoriety: INBX and SGMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INBX: 18% vs. SGMT: 30%
Market capitalization -- INBX: $1.2B vs. SGMT: $439.06M
INBX [@Biotechnology] is valued at $1.2B. SGMT’s [@Biotechnology] market capitalization is $439.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INBX’s FA Score shows that 1 FA rating(s) are green whileSGMT’s FA Score has 0 green FA rating(s).

  • INBX’s FA Score: 1 green, 4 red.
  • SGMT’s FA Score: 0 green, 5 red.
According to our system of comparison, INBX is a better buy in the long-term than SGMT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INBX’s TA Score shows that 3 TA indicator(s) are bullish while SGMT’s TA Score has 4 bullish TA indicator(s).

  • INBX’s TA Score: 3 bullish, 4 bearish.
  • SGMT’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, INBX is a better buy in the short-term than SGMT.

Price Growth

INBX (@Biotechnology) experienced а +0.61% price change this week, while SGMT (@Biotechnology) price change was +0.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.22%. For the same industry, the average monthly price growth was -8.12%, and the average quarterly price growth was +2790.29%.

Reported Earning Dates

INBX is expected to report earnings on Aug 19, 2026.

SGMT is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Biotechnology (-1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INBX($1.2B) has a higher market cap than SGMT($439M). SGMT YTD gains are higher at: 20.101 vs. INBX (3.861). SGMT has higher annual earnings (EBITDA): -48.74M vs. INBX (-114.82M). INBX has more cash in the bank: 162M vs. SGMT (105M). SGMT has less debt than INBX: SGMT (39K) vs INBX (181M). INBX has higher revenues than SGMT: INBX (1.3M) vs SGMT (0).
INBXSGMTINBX / SGMT
Capitalization1.2B439M274%
EBITDA-114.82M-48.74M236%
Gain YTD3.86120.10119%
P/E Ratio0.20N/A-
Revenue1.3M0-
Total Cash162M105M154%
Total Debt181M39K464,103%
FUNDAMENTALS RATINGS
INBX: Fundamental Ratings
INBX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
55
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
9
SEASONALITY SCORE
1..100
46

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INBXSGMT
RSI
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
N/A
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 5 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 4 days ago
87%
Aroon
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
INBX
Daily Signal:
Gain/Loss:
SGMT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ALLIX114.141.36
+1.21%
AB Large Cap Growth I
AASCX32.590.03
+0.09%
Thrivent Mid Cap Stock A
OAZGX41.24-0.15
-0.36%
Oakmark Global R6
USPFX37.08-0.14
-0.38%
Union Street Partners Value Advisor
FCENX15.13-0.07
-0.46%
Franklin International Core Equity Adv

INBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if INBX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
-3.16%
AXON - INBX
48%
Loosely correlated
+0.47%
SNTI - INBX
39%
Loosely correlated
-5.52%
VCYT - INBX
37%
Loosely correlated
-22.52%
SGMT - INBX
37%
Loosely correlated
-2.74%
ARRY - INBX
37%
Loosely correlated
+2.76%
More

SGMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMT has been loosely correlated with VIR. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMT jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMT
1D Price
Change %
SGMT100%
-2.74%
VIR - SGMT
41%
Loosely correlated
-2.70%
EDIT - SGMT
40%
Loosely correlated
-4.09%
SYRE - SGMT
37%
Loosely correlated
-3.12%
INBX - SGMT
37%
Loosely correlated
-3.16%
GOSS - SGMT
37%
Loosely correlated
-4.94%
More